Advertisement
Screener

DiaMedica Therapeutics Inc. (DMAC) Cash Flow Breakdown

DiaMedica Therapeutics Inc. Cash Flow Breakdown

Cash flow breakdown shows where DiaMedica Therapeutics Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $29.06M went out.
  • Fiscal year ended 2025-12-31: from investing, $2.19M went out.
  • Fiscal year ended 2025-12-31: from financing, $43.88M came in.
  • Fiscal year ended 2025-12-31: change in cash, $12.62M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$29.06M-$2.19M$43.28M$594.00K*$12.62M
2024-12-31-$22.08M$8.56M$11.75M-$1.52M
2023-12-31-$18.73M-$18.30M$36.85M-$185.00K
2022-12-31-$11.51M$11.54M$0.00$21.00K
2021-12-31-$12.25M-$20.54M$29.85M-$2.70M
2020-12-31-$9.19M-$16.13M$28.80M$3.53M
2019-12-31-$9.10M-$3.91M$75.00K-$12.94M
2018-12-31-$5.70M-$50.00K$14.73M$6.49M*$15.47M
2017-12-31-$3.90M-$22.00K$2.92M$622.00K*-$383.00K

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$8.11M*$8.24M*$135.00K*
2026-03-31-$9.08M-$2.11M$420.00K-$10.78M
2025-12-31-$7.76M*$8.00M*$11.76M*
2025-09-30-$6.55M*-$25.77M*$31.53M*
2025-06-30-$7.60M*$8.96M*$163.00K*
2025-03-31-$7.15M$6.62M$94.00K-$436.00K
2024-12-31-$6.43M*$5.21M*$0.00*
2024-09-30-$4.47M*-$5.58M*$0.00*
2024-06-30-$4.52M*$4.74M*$7.00K*$11.74M*
2024-03-31-$6.65M$4.21M$0.00-$2.45M
2023-12-31-$3.81M*$6.12M*$0.00*
2023-09-30-$4.80M*$1.20M*-$4.00K*
2023-06-30-$5.03M*-$28.13M*$36.85M*
2023-03-31-$5.09M$2.51M-$2.58M
2022-12-31-$2.77M*$4.72M*$0.00*
2022-09-30-$2.36M*$2.07M*$0.00*
2022-06-30-$2.50M*$2.53M*$0.00*
2022-03-31-$3.89M$2.21M$0.00-$1.68M
2021-12-31-$2.80M*-$8.69M*-$18.00K*
2021-09-30-$3.05M*-$12.83M*$29.87M*
2021-06-30-$2.09M*$989.00K*$0.00*
2021-03-31-$4.31M-$9.00K$244.00K-$4.08M
2020-12-31-$3.02M*$667.00K*-$67.00K*
2020-09-30-$2.35M*-$14.00M*$21.19M*
2020-06-30-$844.00K*$2.50M*$0.00*
2020-03-31-$2.98M-$5.30M$7.68M-$583.00K
2019-12-31-$1.86M*$1.01M*$0.00*-$858.00K*
2019-09-30-$1.23M*$3.00M*$0.00*$1.77M*
2019-06-30-$2.87M*$3.01M*$215.00K*
2019-03-31-$3.13M-$10.93M-$14.06M
2018-12-31-$1.90M*$13.00K*$0.00*$14.81M*$12.93M*
2018-09-30-$1.84M*-$21.00K*$0.00*-$1.83M*
2018-06-30-$1.02M*-$10.00K*-$984.00K*
2018-03-31-$935.00K-$32.00K$6.32M*$5.36M

Similar stocks

Stock NameCountryMarket CapPE Ratio
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
Turn Therapeutics Inc. (TTRX)United States$0.397B-25.68